Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study.

Abergel A, Asselah T, Metivier S, Loustaud-Ratti V. Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study. Lancet Infect Dis. 2016;16(4):459-464.

Publication Type:

Journal Article

Authors:

Abergel, A.; Asselah, T.; Metivier, S.; Loustaud-Ratti, V.

Source:

Lancet Infect Dis., Volume 16, Issue 4, p.459-464 (2016)

Cited On:

Export Citation:
RIS Format
Top